XENE Q1 2021 Earnings — Xenon Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

XENEXenon Pharmaceuticals Inc.

$5B

Q1 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$4M-38.4% YoY

Gross Profit

-$12M-274.2% margin

Operating Income

-$16M-368.5% margin

Net Income

-$16M-361.7% margin

EPS (Diluted)

$-0.43

QoQ Revenue Growth

-15.4%

Cash Flow

Operating Cash Flow

-$21M

Free Cash Flow

-$21M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$291M

Total Liabilities

$14M

Stockholders' Equity

$276M

Cash & Equivalents

$88M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$7M	-38.4%
Gross Profit	-$12M	$7M	-268.8%
Operating Income	-$16M	-$8M	-99.9%
Net Income	-$16M	-$7M	-110.6%

Revenue Segments

License And Service

$4M100%